UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001799
Receipt number R000002169
Scientific Title Analysis of usefulness of serum TFF1, 2, 3 mesurement for gastric cancer screening
Date of disclosure of the study information 2009/04/01
Last modified on 2014/03/25 09:56:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of usefulness of serum TFF1, 2, 3 mesurement for gastric cancer screening

Acronym

Gastric cancer screening using serum TFF1, 2, 3

Scientific Title

Analysis of usefulness of serum TFF1, 2, 3 mesurement for gastric cancer screening

Scientific Title:Acronym

Gastric cancer screening using serum TFF1, 2, 3

Region

Japan


Condition

Condition

gastric cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To know whether serum TFF1, 2, and 3 can be good screening markers for gastric cancer in health check receiving people.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Whether serum TFF1, 2, and 3 value can select people who should receive endoscopic examination for gastric cancer.

Key secondary outcomes

Whether serum TFF1, 2 and 3 are better screening marker for gastric cancer than pepsinogen method.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Who agreed to participate in the study among people who receive health check program in NTT east Japan Kanto Hospital

Key exclusion criteria

Nothing

Target sample size

20000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sachiyo Nomura

Organization

Graduate School of Medicine, the University of Tokyo

Division name

Department of Gastrointestinal Surgery

Zip code


Address

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

TEL

03-3815-5411

Email

snomura-gi@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nobuyuki Matsuhashi

Organization

NTT east Japan Kanto Hospital

Division name

Endoscopy division

Zip code


Address

5-9-22 Higashi Gotanda, Shinagawa-ku

TEL

03-3448-6245

Homepage URL


Email

nmatuha-tky@umin.ac.jp


Sponsor or person

Institute

Serum TFF analyzing group

Institute

Department

Personal name



Funding Source

Organization

The University of Tokyo

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

NTT East Japan Kanto Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2009 Year 01 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 03 Month 01 Day

Date trial data considered complete

2012 Year 09 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information

The participants receive upper gastrointestinal endoscopy and are diagnosed whether they have gastric caner or not.


Management information

Registered date

2009 Year 03 Month 25 Day

Last modified on

2014 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002169


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name